Abstract:Study question: Is serum fetuin-B associated with the fertilization rate in in vitro fertilization (IVF)? Summary answer: Serum fetuin-B increased during IVF cycles when oocytes could be fertilized while remained unchanged in fertilization failure. What is known already: Fetuin-B deficiency in mice causes premature zona pellucida hardening mediated by the zona protease ovastacin. Thus fetuin-B deficiency renders females infertile. Study design, size, duration: We determined the human serum fetuin-B reference range, studying longitudinally, over the course of one month, five male and seven female volunteers without hormone treatment and four female volunteers on varying hormonal contraception. We sampled blood and determined serum fetuin-B, luteinizing hormone (LH), estradiol (E2) and progesterone (P4). In addition, we determined serum fetuin-B and estradiol in eight women undergoing intracytoplasmatic sperm injection (ICSI, nine ICSI cycles) and 19 women undergoing IVF (21 IVF cycles) after ovarian stimulation with recombinant human follicular stimulating hormone (rFSH) and/or a combined medication of FSH and LH. At least three blood samples were analyzed in each cycle. We compared serum fetuin-B and follicular fluid fetuin-B in nine patients by measuring follicular fetuin-B in pooled follicular fluid, and in fluid obtained from individual follicles. Samples were drawn from January 2012 to March 2014. Participants/materials, setting, method: All volunteers and patients gave informed consent. Fetuin-B was measured employing a commercial sandwich enzyme-linked immunosorbent assay. Serum fetuin-B was determined as duplicates in 5 male (34 ± 14.6 years) and 11 female volunteers (29.4 ± 4.1 years) as well as in female volunteers on hormonal contraception (30.0 ± 6.5 years). The duplicate standard deviation was 4.0 ± 2.3%. The contraceptive drugs were mono or combined preparations containing 0-0.03 mg ethinyl estradiol, and 0.15-3.0 mg of various progestins. In addition, serum fetuin-B was determined as triplicates in 27 female patients undergoing conventional IVF (19) or ICSI (8). The triplicate standard deviation was 3.3 ± 1.8%. IVF was declared as 'successful', if at least one oocyte was fertilized, and 'unsuccessful', if no oocyte could be fertilized. Patient age was 34.4 ± 4.4 years in successful IVF, and 35.4 ± 3.3 years in unsuccessful IVF. Serum and follicular fluid of patients undergoing controlled ovarian hyperstimulation were analyzed. Serum was drawn at the day of follicle aspiration. Main results and the role of chance: Serum fetuin-B and follicular fluid fetuin-B were not significantly different in six out of nine patients suggesting, in principle, free exchange of fetuin-B between serum and follicular fluid. Thus serum fetuin-B may be used as a proxy of follicular fluid fetuin-B. Serum fetuin-B increased during successful IVF cycles (n = 15, P < 0.0001), but did not change in unsuccessful IVF cycles (n = 6, P = 0.118) despite increased estradiol levels (P = 0.0019 and P = 0.0254, respectively). Limitations, reasons for caution: The female volunteers self-reported their respective hormone medication. Medication was verified by serum estradiol, LH and progesterone measurements. For oocyte harvesting, the vaginal wall was punctured once only to minimize co-morbidity. Low grade cross-contamination of individual follicular fluid aspirates and contamination of the follicular fluid with small amounts of blood were inevitable. Samples were routinely checked for the presence of hemoglobin that would suggest blood contamination. Only samples containing <250 erythrocyte equivalents/µl were used for analysis. Wider implications of the finding: Serum fetuin-B may be used as a marker to predict the fertilization success in IVF. Fetuin-B levels attained during IVF stimulation may help to make an informed decision whether oocytes should be fertilized by IVF or by ICSI to overcome the zona pellucida as a barrier. Study funding/competing interests: The research was supported by a grant from Deutsche Forschungsgemeinschaft and by the START program of the Medical Faculty of RWTH Aachen University. J.F., E.D., J.N., B.R. and W.J.-D. declare that they are named inventors on the RWTH Aachen University patent application EP 13157317.2, 'Use of fetuin-B for culture of oocytes', applied for by RWTH Aachen University.

The Relationships among Plasma Fetuin-B, Thyroid Autoimmunity, and Fertilization Rate In Vitro Fertilization and Embryo Transfer

IVF/ICSI Outcomes of Euthyroid Infertile Women with Thyroid Autoimmunity: Does Treatment with Aspirin Plus Prednisone Matter?

TGF-β1 Levels in Follicular Fluid of Patients with Endometriosis Associated Infertility

[Correlation of Fetuin-B Concentrations in Serum and Follicular Fluid with Outcomes of in Vitro Fertilization].

Impact of Thyroid Autoimmunity on in Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes and Fetal Weight.

Serum and Follicular Fluid Fetuin-B Levels Are Correlated with Fertilization Rates in Conventional IVF Cycles.

Relationship Between Antithyroid Antibody And Pregnancy Outcome Following In Vitro Fertilization And Embryo Transfer

Association of high fetuin-B concentrations in serum with fertilization rate in IVF: a cross-sectional pilot study

Impact of Thyroid Cancer Treatment on Assisted Reproductive Technology Outcomes in Women with Infertility

Basic thyroid function and pregnancy outcome in IVF-ET

Impact of thyroid autoimmunity and vitamin D on in vitro fertilization/intracytoplasmic sperm injection outcomes among women with normal thyroid function

Thyroid autoimmunity and vitamin D: Effects on in vitro fertilization/intracytoplasmic sperm injection laboratory outcomes

Negative Association between Thyroid Autoimmunity and High Miscarriage Rate In Vitro Fertilization and Embryo Transfer

Impact of thyroid autoimmunity on pregnancy outcomes in euthyroid patients with recurrent implantation failure.

Influence Of Hypothyroidism On In Vitro Fertilization Outcomes

Impaired embryo development potential associated with thyroid autoimmunity in euthyroid infertile women with diminished ovarian reserve

[Effects of Thyroid Autoimmunity on Pregnancy Outcomes in Euthyroid Women Receiving in Vitro Fertilization: a Meta-Analysis].

Evaluation of the Relationship Between Serum TSH Levels and Pregnancy Outcomes of IVF/ICSI Patients in Follicular Phase Long-Acting Long Protocol

Relationship Between Serum Antisperm Antibodies and Anticardiolipin Antibodies and Clinical Pregnancy Outcome in an in Vitro Fertilization and Embryo Transfer Program.

Serum and follicular fluid thyroid hormone levels and assisted reproductive technology outcomes

Associations Betweenphthalatemetaboliteconcentrationsinfollicularfluidand Reproductive OutcomesamongWomenUndergoing in Vitro Fertilization/ Intracytoplasmic SpermInjectionTreatment